In response to DNA damage, eukaryotic cells initiate a complex signalling pathway, termed the DNA damage response (DDR), which coordinates cell cycle arrest with DNA repair. Studies have shown that oncogene-induced senescence, which provides a barrier to tumour development, involves activation of the DDR 1-3 . Using a genome-wide RNA interference (RNAi) screen, we have identified 17 factors required for oncogenic BRAF to induce senescence in primary fibroblasts and melanocytes 4 . One of these factors is an F-box protein, FBXO31, a candidate tumour suppressor encoded in 16q24.3, a region in which there is loss of heterozygosity in breast, ovarian, hepatocellular and prostate cancers 5-9 . Here we study the cellular role of FBXO31, identify its target substrate and determine the basis for its growth inhibitory activity. We show that ectopic expression of FBXO31 acts through a proteasome-directed pathway to mediate the degradation of cyclin D1, an important regulator of progression from G1 to S phase, resulting in arrest in G1. Cyclin D1 degradation results from a direct interaction with FBXO31 and is dependent on the F-box motif of FBXO31 and phosphorylation of cyclin D1 at Thr 286, which is known to be required for cyclin D1 proteolysis. The involvement of the DDR in oncogene-induced senescence prompted us to investigate the role of FBXO31 in DNA repair. We find that DNA damage induced by c-irradiation results in increased FBXO31 levels, which requires phosphorylation of FBXO31 by the DDR-initiating kinase ATM. RNAi-mediated knockdown of FBXO31 prevents cells from undergoing efficient arrest in G1 after c-irradiation and markedly increases sensitivity to DNA damage. Finally, we show that a variety of DNA damaging agents all result in a large increase in FBXO31 levels, indicating that induction of FBXO31 is a general response to genotoxic stress. Our results reveal FBXO31 as a regulator of the G1/S transition that is specifically required for DNA damage-induced growth arrest.
In response to DNA damage, eukaryotic cells initiate a complex signalling pathway, termed the DNA damage response (DDR), which coordinates cell cycle arrest with DNA repair. Studies have shown that oncogene-induced senescence, which provides a barrier to tumour development, involves activation of the DDR [1] [2] [3] . Using a genome-wide RNA interference (RNAi) screen, we have identified 17 factors required for oncogenic BRAF to induce senescence in primary fibroblasts and melanocytes 4 . One of these factors is an F-box protein, FBXO31, a candidate tumour suppressor encoded in 16q24.3, a region in which there is loss of heterozygosity in breast, ovarian, hepatocellular and prostate cancers [5] [6] [7] [8] [9] . Here we study the cellular role of FBXO31, identify its target substrate and determine the basis for its growth inhibitory activity. We show that ectopic expression of FBXO31 acts through a proteasome-directed pathway to mediate the degradation of cyclin D1, an important regulator of progression from G1 to S phase, resulting in arrest in G1. Cyclin D1 degradation results from a direct interaction with FBXO31 and is dependent on the F-box motif of FBXO31 and phosphorylation of cyclin D1 at Thr 286, which is known to be required for cyclin D1 proteolysis. The involvement of the DDR in oncogene-induced senescence prompted us to investigate the role of FBXO31 in DNA repair. We find that DNA damage induced by c-irradiation results in increased FBXO31 levels, which requires phosphorylation of FBXO31 by the DDR-initiating kinase ATM. RNAi-mediated knockdown of FBXO31 prevents cells from undergoing efficient arrest in G1 after c-irradiation and markedly increases sensitivity to DNA damage. Finally, we show that a variety of DNA damaging agents all result in a large increase in FBXO31 levels, indicating that induction of FBXO31 is a general response to genotoxic stress. Our results reveal FBXO31 as a regulator of the G1/S transition that is specifically required for DNA damage-induced growth arrest.
We studied FBXO31 function in human SK-MEL-28 melanoma cells. We first tested whether, as in breast cancer cell lines 9 , ectopic expression of FBXO31 could induce G1 arrest in SK-MEL-28 cells. Fluorescence-activated cell sorting (FACS) analysis revealed, as expected, that treatment of SK-MEL-28 cells with nocodazole resulted in G2/M arrest ( Fig. 1a ). Ectopic expression of FBXO31 prevented the nocodazole-induced G2/M block and instead substantially increased the fraction of cells in G1. Identical results were obtained in cells ectopically expressing FBXO31 in the absence of nocodazole ( Supplementary Fig. 1 ). Moreover, ectopic expression of FBXO31 blocked DNA synthesis ( Fig. 1b) . Notably, ectopic expression of FBXO31 also markedly inhibited the growth of SK-MEL-28 cells in culture ( Supplementary Fig. 2a ) and SK-MEL-28 mouse xenografts ( Supplementary Fig. 2b ).
F-box proteins are best known for their role as the substrate-recognition components of the SCF (SKP/Cullin/F-box protein) class of E3 ubiquitin ligases 10 . To investigate the basis by which FBXO31 induces G1 arrest, we analysed a panel of cell cycle regulatory proteins by immunoblot analysis after ectopic expression of FBXO31. Figure 1c shows that after expression of FBXO31, but not vector alone ( Supplementary Fig. 3 ), the level of cyclin D1, a key regulator of the G1/S-phase transition 11 , markedly declined. In contrast, the levels of other G1 cyclins and the G2/M regulator cyclin B1 were unaffected. Ectopic FBXO31 expression also had no effect on the levels of all cyclin-dependent kinases (CDKs) ( Fig. 1d ) and CDK inhibitors ( Fig. 1e ) examined. As expected, the decrease in cyclin D1 levels was accompanied by an increase in the fraction of cells in G1 ( Supplementary Fig. 4 ). RNAi-mediated knockdown of cyclin D1 in SK-MEL-28 cells resulted in a similar G1 arrest ( Supplementary  Fig. 5 ). Collectively, these results suggest that FBXO31 induces G1 arrest through the selective degradation of cyclin D1.
We next sought to determine whether the FBXO31-mediated decrease in cyclin D1 resulted from proteasomal degradation. Figure 2a shows that addition of the proteasome inhibitor lactacystin blocked the ability of ectopically expressed FBXO31 to decrease cyclin D1 levels. Consistent with this result was our observation that levels of CCND1 messenger RNA (encoding cyclin D1) were unaffected by ectopic FBXO31 expression ( Fig. 2b) . Moreover, after ectopic expression of FBXO31, the half-life of cyclin D1 was substantially decreased ( Supplementary Fig. 6 ).
The proteasome-mediated degradation of cyclin D1 requires phosphorylation on Thr 286 (refs 12-14) . We therefore tested whether FBXO31-mediated degradation of cyclin D1 was dependent on Thr 286 phosphorylation. SK-MEL-28 cells were stably transfected with a plasmid expressing haemagglutinin (HA)-tagged cyclin D1 or a cyclin D1 derivative bearing a threonine-to-alanine substitution at position 286 (cyclin D1(T286A)) 12 and then transduced with a retrovirus expressing FBXO31. Figure 2c shows that ectopic expression of FBXO31 resulted in the degradation of wild-type cyclin D1 but not the cyclin D1(T286A) mutant. After expression of cyclin D1(T286A), ectopically expressed FBXO31 failed to induce efficient G1 arrest ( Fig. 2d and Supplementary Fig. 7a ) or to block DNA synthesis ( Fig. 2e ).
To test whether FBXO31 and cyclin D1 interact, we performed coimmunoprecipitation experiments. SK-MEL-28 cells transduced with a retrovirus expressing Myc-tagged FBXO31 were stably transfected with a plasmid expressing HA-tagged cyclin D1 and treated with lactacystin to prevent cyclin D1 degradation (see Fig. 2a ). The results of Fig. 3a show the presence of cyclin D1 in the FBXO31 immunoprecipitate, which was most evident when lactacystin was added. A similar result was obtained in the reciprocal co-immunoprecipitation. In contrast, FBXO31 failed to interact with cyclin D1(T286A) (Supplementary Fig. 7b ). Figure 3a also shows, in agreement with previous reports 9 , that FBXO31 was part of the SCF complex, as demonstrated by its association with SKP1 and CUL1. The co-immunoprecipitation experiment of Fig. 3b shows that there was also an interaction between the endogenous FBXO31 and cyclin D1 proteins.
To determine whether the F-box motif of FBXO31 was required for cyclin D1 proteolysis, we used an FBXO31 derivative in which the F-box had been deleted (FBXO31DF) 9 . In contrast with wild-type FBXO31, ectopic expression of FBXO31DF did not result in decreased levels of cyclin D1 (Fig. 3c ). Consistent with this finding was our observation that ectopic expression of FBXO31, but not that of FBXO31DF, resulted in polyubiquitylation of cyclin D1 (Fig. 3d ). As expected, cyclin D1(T286A) was not polyubiquitylated. Figure 3e shows that FBXO31 directed polyubiquitylation of cyclin D1 in vitro in the absence of any other F-box protein.
As noted above, it has previously been shown that oncogeneinduced senescence involves activation of the DDR 1-3 . We therefore considered the possibility that in addition to its role in BRAF-induced senescence 4 , FBXO31 might also be involved in mediating G1 arrest after DNA damage. Figure 4a shows that after induction of DNA damage by c-irradiation, the levels of FBXO31 increased and, in agreement with previous reports 15 , this was accompanied by a decrease in cyclin D1 levels. Quantitative real-time reverse-transcriptase-mediated polymerase chain reaction (RT-PCR) confirmed that FBXO31 and CCND1 mRNA levels were unchanged after c-irradiation (Supplementary Fig. 8 ). Consistent with this finding was our observation that in untreated SK-MEL-28 cells the low levels of FBXO31 resulted, at least in part, from proteasomal degradation ( Supplementary Fig. 9 ). RNAi-mediated knockdown of FBXO31 prevented the decrease in cyclin D1 after c-irradiation ( Fig. 4b and Supplementary Fig. 10 ). In support of this conclusion, c-irradiation decreased the half-life of cyclin D1 in SK-MEL-28 cells expressing a control non-silencing short hairpin RNA (shRNA) but not an FBXO31 shRNA ( Supplementary  Fig. 11 ). In FBXO31 knockdown (KD) SK-MEL-28 cells, c-irradiation failed to induce G1 arrest ( Fig. 4c and Supplementary Fig. 12 ).
Phosphorylation of cyclin D1 at Thr 286 can be mediated by glycogen synthase kinase 3b (GSK3b) 12, 13 and through a mitogenactivated protein (MAP) kinase pathway 14 . We found that GSK3b was not required for cyclin D1 degradation after c-irradiation, whereas blocking MAP kinase signalling with a chemical inhibitor of MAP kinase/ERK kinase (MEK) prevented cyclin D1 degradation after c-irradiation ( Supplementary Fig. 13 ).
ATM is a serine-threonine protein kinase with a critical role in the DDR [16] [17] [18] . In response to DNA double-strand breaks, ATM is autophosphorylated on several residues including Ser 1981, and functions by phosphorylating, and in many cases stabilizing, several downstream protein targets that function in the DDR 16, 19 . FBXO31 contains two putative ATM phosphorylation sites at amino-acid residues 278/ 279 and 400/401, the former of which is conserved (Fig. 4d, top) . Coimmunoprecipitation experiments revealed that FBXO31 and ATM interacted ( Supplementary Fig. 14) . A glutathione S-transferase (GST) fusion protein containing the 278/279 serine-glutamine site was phosphorylated by ATM in vitro (Fig. 4d, bottom) , and an FBXO31 derivative bearing a serine-to-alanine mutation at position 278 failed to accumulate after c-irradiation (Fig. 4e ) or on co-transfection with ATM (Fig. 4f ). In ATM KD SK-MEL-28 cells, FBXO31 was not induced after c-irradiation and, accordingly, cyclin D1 levels remained unchanged ( Fig. 4g and Supplementary Fig. 15 ). a, Co-immunoprecipitation of FBXO31 with cyclin D1 and SCF complex components. The FBXO31-cyclin D1 interaction was specific ( Supplementary Fig. 18 ) and predominantly cytoplasmic ( Supplementary  Fig. 19 ). IP, immunoprecipitation. b, Co-immunoprecipitation of endogenous FBXO31 and cyclin D1. c, Cyclin D1 levels in SK-MEL-28 cells ectopically expressing vector, FBXO31 or FBXO31DF. d, In vivo ubiquitylation assay. Polyubiquitylated cyclin D1 was detected by immunoprecipitation of Flag-tagged ubiquitin followed by immunoblotting for HA-cyclin D1. e, In vitro ubiquitylation assay. Immunopurified SCF complexes were incubated with GST-cyclin D1, Erk2, E1, E2, ATP and ubiquitin. Knockdown of FBXO31 substantially increased the sensitivity of SK-MEL-28 cells to c-irradiation (Fig. 4h ). Taken together, these results indicate that after c-irradiation ATM phosphorylates FBXO31 directly, which results in the stabilization of FBXO31 and the subsequent degradation of cyclin D1.
Finally, we tested whether other DNA-damaging agents also induced FBXO31. Figure 4i shows that FBXO31 levels greatly increased and cyclin D1 levels declined to varying extents after ultraviolet irradiation, X-ray irradiation, oxidative stress (H 2 O 2 ) or addition of the chemotherapeutic DNA-damaging agents etoposide, adriamycin, cisplatin or fluorouracil. On the basis of these results we conclude that induction of FBXO31 is a general response to genotoxic stress.
Taken together, the results reported here show that FBXO31 is induced by DNA damage and, once stabilized, targets cyclin D1 for degradation by ubiquitin-mediated proteolysis, leading to G1 arrest (Fig. 4j) . Our results address a long-standing problem in the DNA repair field. It has previously been shown that G1 arrest after DNA damage occurs in a two-phase response, referred to as initiation and maintenance 15 . The maintenance phase is a slow response that is due primarily to p53-dependent transcription induction of the cell cycle inhibitor p21. By contrast, initiation is a rapid, p53-independent response that results primarily from cyclin D1 degradation. However, the mechanistic basis by which cyclin D1 becomes rapidly degraded after genotoxic stress remained to be determined. Our results indicate that the initiation of G1 arrest after genotoxic stress is due to the induction of FBXO31, which then interacts with cyclin D1 and mediates its degradation.
Two other F-box proteins, FBXO4 (also called FBX4) and FBXW8, have previously been reported to mediate cyclin D1 degradation 14, 20 . FBXO31, FBXO4 and FBXW8 probably function through a common mechanism, as demonstrated by the observations that all three proteins are incorporated into the SCF complex and require the phosphorylation of cyclin D1 at Thr 286 to direct cyclin D1 degradation. However, an important distinction between the three proteins is that FBXO4 and FBXW8 seem to be required for normal cell cycle progression 14, 20 , whereas we find no evidence for a cell-cycle defect or a decreased growth rate after knockdown of FBXO31 (ref. 4; see above and data not shown). Moreover, in contrast with FBXO31, the levels of FBXO4 and FBXW8 do not increase after c-irradiation ( Supplementary Fig. 16a ), and knockdown of FBXO4 or FBXW8 does not affect cyclin D1 degradation in c-irradiated SK-MEL-28 cells ( Supplementary Fig. 16b ). The results presented here reveal that FBXO31 is a dedicated checkpoint protein whose function is to arrest cells after genotoxic stress.
METHODS SUMMARY
Cell cycle analysis. For FACS analysis, SK-MEL-28 cells transduced with retrovirus (multiplicity of infection 20) expressing FBXO31 or empty vector, in the presence or absence of a plasmid expressing cyclin D1 or cyclin D1(T286A), were collected 48 h after infection with the virus, after having been treated with 8 mg ml 21 of nocodazole (Sigma) for the final 16 h. Cells were washed with cold PBS and fixed with ethanol. Treatment with nocodazole for c-irradiation-treated cells was performed as described previously 15 after treatment of SK-MEL-28 cells with a non-silencing or FBXO31 shRNA. FACS samples were analysed with a FACSCalibur system (BD Biosciences).
For labelling with bromodeoxyuridine (BrdU), SK-MEL-28 cells transduced with retrovirus expressing FBXO31 or empty vector, in the presence or absence of a plasmid expressing cyclin D1 or cyclin D1(T286A), were collected 48 h after virus infection, after having been treated with BrdU (20 mM) for the final 4 h. Cells were then harvested, fixed in 70% ethanol and stained sequentially with an anti-BrdU mouse antibody (Calbiochem), fluorescein isothiocyanate-conjugated goat antimouse antibody (Calbiochem) and 4,6-diamidino-2-phenylindole (DAPI; Sigma). DAPI-stained cells were scored as BrdU-positive or BrdU-negative with a Zeiss Axiophot 2 fluorescence microscope; about 500-600 cells per sample were scored. Ubiquitylation assays. For in vivo assays, SK-MEL-28 cells were co-transfected with plasmids expressing HA-cyclin D1 or HA-cyclin D1(T286A) and Flag-tagged ubiquitin and then transduced with an FBXO31 or FBXO31DF retrovirus. Polyubiquitylated cyclin D1 was detected by immunoprecipitation of ubiquitin with an anti-Flag antibody, followed by immunoblotting with an anti-HA antibody for cyclin D1. For in vitro assays, 293T cells were transfected with vectors encoding Myc-FBXO31, Myc-CUL1, Myc-SKP1 and Myc-ROC1. The SCF FBXO31 (E3) complexes were immunopurified from the cell lysate using an anti-Myc antibody and incubated with in vitro-translated GST-tagged cyclin D1 in the presence of purified, recombinant active Erk2, E1, E2 (UbcH5A), ATP and ubiquitin.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
